Lucy Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
21 Hickory Dr Ste 2B, Waltham, Massachus...Phone Number
(617) 249-4812Website
www.lucytherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Lucy Therapeutics
Lucy Therapeutics, a biotech with a unique mitochondrial platform, is developing small molecule treatments for neurological diseases along with a unique peripheral mitochondrial biomarker. LucyTx's platform has led to the discovery of targets to improve central energetic dysfunctions in these diseases and address their complex organ symptomatology selectively in diseased vs. healthy cells. LucyTx interrogates complex biology with well-defined molecules to answer key questions about the pathways critical for disease modification.Explore more
Lucy Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lucy Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Lucy Therapeutics is spiking on competitors!
Click to see if Lucy Therapeutics had a recent Job posting/layoffs
Check if Lucy Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Lucy Therapeutics
Product Launch: Get notified when Lucy Therapeutics launches new products
Lucy Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lucy Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Lucy Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Lucy Therapeutics
Compare insights from companies similar to Lucy Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lucy Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lucy Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lucy Therapeutics.
Lucy Therapeutics financials insights
Gather financial insights about Lucy Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Grant
$4.9M
2024
Other Financing Round
$12.5M
Lucy Therapeutics Tech Stack
A closer look at the technologies used by Lucy Therapeutics
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Funding
Funding
New Hire
Executive Move
New Hire
Executive Move
Funding
Lucy Therapeutics News & Media
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, June 12, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and...Lucy Therapeutics Secures New Funding to Advance New Alzheimer’s and Parkinson’s Treatments
WALTHAM, Mass.--(BUSINESS WIRE)--Lucy Therapeutics, Inc. (LucyTx) today announced it has raised $12.5 million in additional funding led by existing investors Engine Ventures and Safar Partners with new participation from Bill Gates, Parkinson’s UK, and the Michael J. Fox Foundation, which provided a $2 million non-dilutive grant. The fresh capital brings LucyTx’s total funding to date to more than $36 million. The investments will further the company’s research programs for Alzheimer’s and ParkLucy Therapeutics Expands Cutting-Edge Medical Research Program
WALTHAM, Mass.--(BUSINESS WIRE)--Lucy Therapeutics (LucyTx) has secured new funding from the International Rett Syndrome Foundation (IRSF) to invest in pioneering treatments for children and adults living with Rett syndrome, and to grow LucyTx’s groundbreaking treatment platform. Rett syndrome affects brain development in infants and toddlers, with missed growth milestones or regression typical around six to 18 months. It can impact speech, walking, eating, and breathing. Rett syndrome affectsLucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced the appointment of Christopher J. Winrow, Ph.D., a neuroscience and translational medicine expert, as Chief Scientific Officer. For more than 20 years, Dr. Winrow’s career in cross-functional drug discovery and development has spanned preclinical research through launch of new medicines a
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lucy Therapeutics
Sign Up For FreeTo access detailed company insights
Lucy Therapeutics, a biotech with a unique mitochondrial platform, is developing small molecule treatments for neurological diseases along with a unique peripheral mitochondrial biomarker. LucyTx's platform has led to the discovery of targets to improve central energetic dysfunctions in these diseases and address their complex organ symptomatology... Read More
